Immuron (IMRN) Accounts Payables (2016 - 2025)
Immuron (IMRN) recorded quarterly Accounts Payables of $15294.3 in Q3 2025, down 97.63% quarter-over-quarter from $644701.1 in Q2 2025, and down 28.39% on a YoY basis from $21358.5 in Q3 2024.
Immuron (IMRN) Accounts Payables (2016 - 2025) Analysis & Trends
Immuron's Accounts Payables history runs 10 years deep, the most recent figure standing at $15294.3 for Q3 2025.
- In Q3 2025, Accounts Payables fell 28.39% year-over-year to $15294.3; the TTM figure through Sep 2025 stood at $15294.3 (down 28.39% YoY), while the FY2025 annual figure was $15294.3, down 28.39% from the prior year.
- Accounts Payables was $15294.3 for Q3 2025 at Immuron, down from $644701.1 in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $842036.5 in Q4 2024 to a low of $10838.7 in Q4 2023.
- Historically, Accounts Payables has averaged $506690.6 across 5 years, with a median of $614391.6 in 2025.
- The sharpest annual moves came in 2021 and 2023: Accounts Payables jumped 23210.63% in 2021, then tumbled 98.58% in 2023.
- A 5-year view of Accounts Payables shows it stood at $555231.3 in 2021, then soared by 37.37% to $762732.0 in 2022, then sank by 98.58% to $10838.7 in 2023, then surged by 7668.8% to $842036.5 in 2024, then plunged by 98.18% to $15294.3 in 2025.
- The last three Accounts Payables figures came in at $15294.3 (Q3 2025), $644701.1 (Q2 2025), and $842036.5 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.05 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 83.00 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 8.64 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 489.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 34.55 Mn |
| 10 | Immuron | 921.61 Mn | 921.58 Mn | - | 15,294.34 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 2, 2025 | 15,294.34 |
| Jun 30, 2025 | 644,701.05 |
| Dec 31, 2024 | 842,036.48 |
| Sep 9, 2024 | 21,358.52 |
| Jun 30, 2024 | 427,608.70 |
| Dec 31, 2023 | 10,838.70 |
| Sep 28, 2023 | 781,835.96 |
| Aug 30, 2023 | 11,927.69 |
| Jun 30, 2023 | 797,199.62 |
| Dec 31, 2022 | 762,732.01 |
| Aug 31, 2022 | 807,311.55 |
| Jun 30, 2022 | 831,510.88 |
| Dec 31, 2021 | 555,231.32 |
| Jun 30, 2021 | 584,082.20 |
| Dec 31, 2020 | 2,381.88 |
| Sep 1, 2020 | 384,397.00 |
| Jun 30, 2020 | 251,941.72 |
| Dec 31, 2019 | 3,843.97 |
| Jun 30, 2019 | 764,858.99 |
| Dec 31, 2018 | 689,326.00 |